Working… Menu

Rivaroxaban in Thrombotic Antiphospholipid Syndrome (TRAPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02157272
Recruitment Status : Terminated (Unbalance in the composite endpoint between arms.)
First Posted : June 5, 2014
Last Update Posted : January 30, 2018
Information provided by (Responsible Party):
Vittorio Pengo, University of Padova